Walgreens Boots Alliance (NASDAQ:WBA) had its price objective boosted by investment analysts at Robert W. Baird from $69.00 to $71.00 in a research report issued on Friday, Stock Target Advisor reports. The brokerage currently has a “neutral” rating on the pharmacy operator’s stock. Robert W. Baird’s price objective would suggest a potential downside of 3.40% from the company’s current price.
Several other equities analysts have also recently issued reports on WBA. BidaskClub upgraded shares of Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a research note on Friday, June 22nd. Cowen cut shares of Walgreens Boots Alliance from an “outperform” rating to a “market perform” rating and set a $104.00 target price on the stock. in a research note on Monday, July 23rd. TheStreet upgraded shares of Walgreens Boots Alliance from a “c+” rating to a “b” rating in a research note on Wednesday, September 12th. ValuEngine upgraded shares of Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a research note on Friday, September 21st. Finally, SunTrust Banks upped their target price on shares of Walgreens Boots Alliance to $75.00 and gave the company a “hold” rating in a research note on Friday. One investment analyst has rated the stock with a sell rating, eleven have assigned a hold rating, seven have assigned a buy rating and two have given a strong buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus price target of $77.56.
Shares of Walgreens Boots Alliance stock opened at $73.50 on Friday. The stock has a market capitalization of $72.35 billion, a P/E ratio of 14.41, a PEG ratio of 1.11 and a beta of 1.04. Walgreens Boots Alliance has a 1 year low of $59.07 and a 1 year high of $80.68. The company has a current ratio of 0.93, a quick ratio of 0.47 and a debt-to-equity ratio of 0.44.
In other Walgreens Boots Alliance news, COO Ornella Barra acquired 1,700,000 shares of the stock in a transaction dated Monday, July 16th. The shares were purchased at an average price of $65.15 per share, for a total transaction of $110,755,000.00. The acquisition was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director William C. Foote sold 2,736 shares of the stock in a transaction that occurred on Thursday, August 2nd. The stock was sold at an average price of $65.99, for a total transaction of $180,548.64. Following the completion of the transaction, the director now owns 10,943 shares in the company, valued at approximately $722,128.57. The disclosure for this sale can be found here. 14.80% of the stock is owned by corporate insiders.
A number of institutional investors have recently added to or reduced their stakes in WBA. BlueMountain Capital Management LLC purchased a new stake in Walgreens Boots Alliance in the 2nd quarter worth approximately $103,000. CSat Investment Advisory L.P. purchased a new stake in Walgreens Boots Alliance in the 2nd quarter worth approximately $104,000. Squar Milner Financial Services LLC purchased a new stake in Walgreens Boots Alliance in the 2nd quarter worth approximately $106,000. Kaizen Advisory LLC increased its holdings in Walgreens Boots Alliance by 128.6% in the 2nd quarter. Kaizen Advisory LLC now owns 1,925 shares of the pharmacy operator’s stock worth $116,000 after acquiring an additional 1,083 shares in the last quarter. Finally, Camarda Financial Advisors LLC purchased a new stake in Walgreens Boots Alliance in the 2nd quarter worth approximately $137,000. 61.92% of the stock is owned by institutional investors.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of general merchandise, including non-prescription drugs, beauty products, photo finishing, seasonal merchandise, greeting cards, and convenience foods through its retail drugstores and convenient care clinics.
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.